Tighe Reardon, Acting Chief Financial Officer at Janux Therapeutics, Inc. (JANX), bought 1,782,649 shares at $17.00 ($10.7M) on 2021-06-15, disclosed to the SEC on 2021-06-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,153,238 | $0 | 0.0% |
| 2 | $17.00 | 629,411 | $10.7M | 100.0% |
| Total | $6.00 avg | 1,782,649 | $10.7M | 100% |
| Filing → |
| THOR | BUY | 2018-12-13 | $6.0M | — | Filing → |